Advanced search
Publication Cover
Expert Review of Medical Devices Volume 17, 2020 - Issue 8
Submit an article Journal homepage
519
Views
30
CrossRef citations to date
0
Altmetric
Special Report

Aptamer-based technology for radionuclide targeted imaging and therapy: a promising weapon against cancer

Luca Filippia Department of Nuclear Medicine, Santa Maria Goretti Hospital, Latina, ItalyCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0003-4423-5496View further author information
ORCID Icon,
Oreste Bagnia Department of Nuclear Medicine, Santa Maria Goretti Hospital, Latina, ItalyView further author information
&
Clara Nervib Department of Medical and Surgical Sciences and Biotechnology, University of Rome “La Sapienza”, Latina, ItalyView further author information
Pages 751-758 | Received 14 Apr 2020, Accepted 08 Jul 2020, Published online: 27 Jul 2020

Citations (30)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (4)

Luca Filippi, Nicoletta Urbano & Orazio Schillaci. (2023) Total-body PET/CT: how will it change theranostics in oncology?. Expert Review of Medical Devices 20:12, pages 999-1003.
Read now
Luca Filippi, Luca Urso, Francesco Bianconi, Barbara Palumbo, Maria Cristina Marzola, Laura Evangelista & Orazio Schillaci. (2023) Radiomics and theranostics with molecular and metabolic probes in prostate cancer: toward a personalized approach. Expert Review of Molecular Diagnostics 23:3, pages 243-255.
Read now
Luca Filippi. (2023) COVID-19 lessons learned: medical devices at the core of global healthcare. A foreword on new challenges for expert review of medical devices!. Expert Review of Medical Devices 20:1, pages 1-3.
Read now
Luca Filippi, Clara Nervi, Ilaria Proietti, Riccardo Pirisino, Concetta Potenza, Olga Martelli, Francesco Equitani & Oreste Bagni. (2020) Molecular imaging in immuno-oncology: current status and translational perspectives. Expert Review of Molecular Diagnostics 20:12, pages 1199-1211.
Read now

Articles from other publishers (26)

Injoo Hwang, Jun Young Lee, Tae-Hyun Kim, Eun Ju Lee, Jeeho Kim, Hyomin Park, Min Goo Hur, Sanghwa Lee & Jeong-Hoon Park. (2024) A radioactive CRISPR interference system using 89Zr-labeled LbCas12a. Journal of Controlled Release 365, pages 703-715.
Crossref
Janke Kleynhans, Mike Machaba Sathekge & Thomas Ebenhan. (2023) Preclinical Research Highlighting Contemporary Targeting Mechanisms of Radiolabelled Compounds for PET Based Infection Imaging. Seminars in Nuclear Medicine 53:5, pages 630-643.
Crossref
Nicolas Lepareur, Barthélémy Ramée, Marie Mougin-Degraef & Mickaël Bourgeois. (2023) Clinical Advances and Perspectives in Targeted Radionuclide Therapy. Pharmaceutics 15:6, pages 1733.
Crossref
Luca Filippi, Viviana Frantellizzi, Paola Bartoletti, Giuseppe De Vincentis, Orazio Schillaci & Laura Evangelista. (2023) Head-to-Head Comparison between FDG and 11C-Methionine in Multiple Myeloma: A Systematic Review. Diagnostics 13:12, pages 2009.
Crossref
Pinghui Li, Chunmei Wang, Wenrui Wang, Xiaoyan Duan & Jianbo Li. (2023) Preliminary evaluation of a 64Cu-labeled DNA aptamer for PET imaging of glioblastoma. Journal of Radioanalytical and Nuclear Chemistry 332:6, pages 2279-2284.
Crossref
Luca Filippi, Viviana Frantellizzi, Giuseppe De Vincentis, Orazio Schillaci & Laura Evangelista. (2023) Clinical Applications of TSPO PET for Glioma Imaging: Current Evidence and Future Perspective—A Systematic Review. Diagnostics 13:10, pages 1813.
Crossref
Luca FilippiMartin W. Brechbiel. (2023) Immunotherapy for Cancer: Something Old, Something New. Cancer Biotherapy and Radiopharmaceuticals 38:4, pages 209-210.
Crossref
María Fernanda García MeliánMaría MorenoHugo CerecettoVictoria Calzada. (2023) Aptamer-Based Immunotheranostic Strategies. Cancer Biotherapy and Radiopharmaceuticals 38:4, pages 246-255.
Crossref
Marko Magdi Abdou Sidrak, Maria Silvia De Feo, Ferdinando Corica, Joana Gorica, Miriam Conte, Luca Filippi, Laura Evangelista, Giuseppe De Vincentis & Viviana Frantellizzi. (2023) Role of Exendin-4 Functional Imaging in Diagnosis of Insulinoma: A Systematic Review. Life 13:4, pages 989.
Crossref
Lisa Agnello, Annachiara d’Argenio, Roberto Nilo, Monica Fedele, Simona Camorani & Laura Cerchia. (2023) Aptamer-Based Strategies to Boost Immunotherapy in TNBC. Cancers 15:7, pages 2010.
Crossref
Miriam Conte, Maria Silvia De Feo, Marko Magdi Abdou Sidrak, Ferdinando Corica, Joana Gorica, Luca Filippi, Orazio Schillaci, Giuseppe De Vincentis & Viviana Frantellizzi. (2023) Radiolabeled Dendrimer Coated Nanoparticles for Radionuclide Imaging and Therapy: A Systematic Review. Pharmaceutics 15:3, pages 867.
Crossref
Niranjan Meher, Henry F. VanBrocklin, David M. Wilson & Robert R. Flavell. (2023) PSMA-Targeted Nanotheranostics for Imaging and Radiotherapy of Prostate Cancer. Pharmaceuticals 16:2, pages 315.
Crossref
Joana Gorica, Maria Silvia De Feo, Ferdinando Corica, Marko Magdi Abdou Sidrak, Miriam Conte, Luca Filippi, Orazio Schillaci, Giuseppe De Vincentis & Viviana Frantellizzi. (2023) Novel Theranostic Approaches Targeting CCR4-Receptor, Current Status and Translational Prospectives: A Systematic Review. Pharmaceuticals 16:2, pages 313.
Crossref
Marek T. Wlodarczyk, Sylwia A. Dragulska, Ying Chen, Mina Poursharifi, Maxier Acosta Santiago, John A. Martignetti & Aneta J. Mieszawska. (2023) Pt(II)-PLGA Hybrid in a pH-Responsive Nanoparticle System Targeting Ovarian Cancer. Pharmaceutics 15:2, pages 607.
Crossref
Bingqian Lin, Feng Xiao, Jinting Jiang, Zhengjia Zhao & Xiang Zhou. (2023) Engineered aptamers for molecular imaging. Chemical Science.
Crossref
Pratikshya Sa & Sanjeeb Kumar Sahoo. 2023. Aptamers Engineered Nanocarriers for Cancer Therapy. Aptamers Engineered Nanocarriers for Cancer Therapy 347 366 .
Yadollah Omidi, Jaleh Barar, Somayeh Vandghanooni, Morteza Eskandani & Hossein Omidian. 2023. Aptamers Engineered Nanocarriers for Cancer Therapy. Aptamers Engineered Nanocarriers for Cancer Therapy 103 139 .
Luca Filippi, Barbara Palumbo, Oreste Bagni, Viviana Frantellizzi, Giuseppe De Vincentis & Orazio Schillaci. (2022) DNA Damage Repair Defects and Targeted Radionuclide Therapies for Prostate Cancer: Does Mutation Really Matter? A Systematic Review. Life 13:1, pages 55.
Crossref
Xinyue Zhao, Nuoya Liu, Yuzhu Song, Jinyang Zhang & Qinqin Han. (2022) Establishment of fumonisin B 1 detection method for catalytic fluorescence detection of aptamer-regulated carbon dots . Analytical Methods 14:40, pages 3953-3960.
Crossref
Dunfang Liu, Qian Xia, Ding Ding & Weihong Tan. (2022) Radiolabeling of functional oligonucleotides for molecular imaging. Frontiers in Bioengineering and Biotechnology 10.
Crossref
Wenyu Song, Yangmeihui Song, Qian Li, Chunhai Fan, Xiaoli Lan & Dawei Jiang. (2022) Advances in aptamer-based nuclear imaging. European Journal of Nuclear Medicine and Molecular Imaging 49:8, pages 2544-2559.
Crossref
Zhiman Liang, Xin Li, Xiaoting Luo, Hongjie Luo, Yajun Chen, Mingliang Cai, Xinxin Zhong, Yingying Fang, Ting Guo, Yusheng Shi & Xingmei Zhang. (2022) The Aptamer Ob2, a novel AChE inhibitor, restores cognitive deficits and alleviates amyloidogenesis in 5×FAD transgenic mice. Molecular Therapy - Nucleic Acids 28, pages 114-123.
Crossref
Aanchal Udaynath Pareri, Arunkumar Singh Koijam & Chandan Kumar. (2022) Breaking the Silence of Tumor Response: Future Prospects of Targeted Radionuclide Therapy. Anti-Cancer Agents in Medicinal Chemistry 22:10, pages 1845-1858.
Crossref
Brian J. Thomas, David Porciani & Donald H. Burke. (2022) Cancer immunomodulation using bispecific aptamers. Molecular Therapy - Nucleic Acids 27, pages 894-915.
Crossref
Nicolas Lepareur & Mickaël Bourgeois. 2022. Handbook of Cancer and Immunology. Handbook of Cancer and Immunology 1 32 .
Greg Shelley, Jinlu Dai, Jill M. Keller & Evan T. Keller. (2021) Pheno-SELEX: Engineering Anti-Metastatic Aptamers through Targeting the Invasive Phenotype Using Systemic Evolution of Ligands by Exponential Enrichment. Bioengineering 8:12, pages 212.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.